Lysotossil cough syrup

Lysotossil is a cough suppressant medication containing Cloperastine fendizoate, specifically formulated for the treatment of dry cough (toux sèche). It is a well-known pharmaceutical product in Europe, particularly within the French and Italian markets.

The brand was originally developed by Zambon, an Italian pharmaceutical company founded in Vicenza in 1906. Zambon remains a family-owned, multinational business with deep roots in Italy. While the company operates manufacturing plants in several countries including Switzerland, Brazil, and China, the primary production for European distribution typically centers around their Italian facilities. The brand continues to be owned and managed by Zambon S.p.A., which is headquartered in Bresso, Milan, Italy. This product is usually distributed locally via national subsidiaries of the Zambon Group.